Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis Bullosa

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 7, 2023

Primary Completion Date

November 17, 2023

Study Completion Date

November 17, 2023

Conditions
Hereditary Epidermolysis Bullosa
Interventions
DRUG

Cannabidiol

Oral solution, taken 3 times a day (morning, noon and evening), 5 mg/kg/day from day D0 to day D4. If not effective and well tolerated, dose increase : 10 mg/kg/day from day D5 to day D9, then 20 mg/kg/day from day D10 to day D29, maximum 800 mg/day

Trial Locations (1)

75015

Hôpital Necker Enfants Malades, Paris

All Listed Sponsors
collaborator

HELEBOR

UNKNOWN

collaborator

Fondation Apicil

OTHER

collaborator

Lions Club International Foundation

OTHER

collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER